Skip to main navigation
  • HOME
  • ABOUT ENZON
  • ROYALTY PRODUCTS
  • INVESTORS & MEDIA

    Investor Relations

    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Stock Quote
    • Stock Lookup
    • Contact Us
  • CONTACT US
  • Request Information
  • Email Alerts
  • Download Library
  • RSS News Feeds
Shareholder Tools
Downloads
Print

Downloads

Date Documents
Mar 17, 2011
  • Add Files
    Enzon Appoints Richard Mulligan, Ph.D. Vice-Chairman of the Board; Adopts Majority Vote Standard for Election of Directors 12.9 KB
Feb 17, 2011
  • Add Files
    Enzon Reports 2010 Results 101.8 KB
Feb 10, 2011
  • Add Files
    Enzon to Release Fourth Quarter 2010 Earnings on Thursday, February 17, 2011; Conference Call and Webcast to Follow 9.5 KB
Jan 10, 2011
  • Add Files
    Enzon to Begin Phase 1 Study of Novel Androgen Receptor mRNA Antagonist in Castration-Resistant Prostate Cancer 13.6 KB
Dec 21, 2010
  • Add Files
    Enzon Board Authorizes Share Repurchase Program 10.9 KB
Dec 15, 2010
  • Add Files
    Enzon Announces the Initiation of Two Phase I Studies in Collaboration with the National Cancer Institute 65.8 KB
Nov 17, 2010
  • Add Files
    Enzon Presents Data at 2010 EORTC-NCI-AACR Meeting 67.5 KB
Nov 11, 2010
  • Add Files
    Code of Conduct and Corporate Values 194.7 KB
Nov 02, 2010
  • Add Files
    Enzon Reports Third Quarter 2010 Results 32.5 KB
Nov 02, 2010
  • Add Files
    Enzon Pharmaceuticals Awarded $1.2 Million in Grants under QTDP Program 10.6 KB

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 3
  • Current page 4
  • Page 5
  • Page 6
  • …
  • Next page Next
  • Last page Last
Displaying 31 - 40 of 190 results

©2017 Enzon Pharmaceuticals, Inc., All Rights Reserved.